Evidence map›Paper›PMID 38221924›Full record

ArticleACS materials Au2024

Cellular Senescence Program is Sensitive to Physical Differences in Polymeric Tissue Scaffolds.

Parul Yadav, Rahul Shah, Anindo Roy, Sibani Jani, Kaushik Chatterjee, Deepak Kumar Saini

Abstract read
In one paragraph

Article in ACS materials Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Parul YadavDepartment of Bioengineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.ORCID https://orcid.org/0000-0002-6257-7783
Rahul ShahDepartment of Materials Engineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.
Anindo RoyDepartment of Materials Engineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.ORCID https://orcid.org/0000-0001-7307-3436
Sibani JaniDepartment of Bioengineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.
Kaushik ChatterjeeDepartment of Bioengineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.ORCID https://orcid.org/0000-0002-7204-2926
Deepak Kumar SainiDepartment of Bioengineering, Indian Institute of Science, C.V Raman Avenue, Bangalore, India 560012.ORCID https://orcid.org/0000-0001-6671-7256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A typical cellular senescence program involves exposing cells to DNA-damaging agents such as ionization radiation or chemotherapeutic drugs, which cause multipronged changes, including increased cell size and volume, the onset of enhanced oxidative stress, and inflammation. In the present study, we examined if the senescence onset decision is sensitive to the design, porosity, and architecture of the substrate. To address this, we generated a library of polymeric scaffolds widely used in tissue engineering of varied stiffness, architecture, and porosity. Using irradiated A549 lung cancer cells, we examined the differences between cellular responses in these 3D scaffold systems and observed that senescence onset is equally diminished. When compared to the two-dimensional (2D) culture formats, there were profound changes in cell size and senescence induction in three-dimensional (3D) scaffolds. We further establish that these observed differences in the senescence state can be attributed to the altered cell spreading and cellular interactions on these substrates. This study elucidates the role of scaffold architecture in the cellular senescence program.

Identifiers

PMID38221924
PMCPMC10786134

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.